Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer

Overview of attention for article published in OncoTargets and therapy, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user
patent: 1 patent

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 33 Mendeley

Summary Policy documents X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 public wall post.

Dove Medical Press, 08 Jan 2013

Profile of cabozantinib and its potential in the treatment of advanced medullary thyroid cancer Medullary thyroid cancer is…